BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ying GS, Pan W, Quinn GE, Daniel E, Repka MX, Baumritter A. Intereye Agreement of Retinopathy of Prematurity from Image Evaluation in the Telemedicine Approaches to Evaluating of Acute-Phase ROP (e-ROP) Study. Ophthalmol Retina 2017;1:347-54. [PMID: 28944318 DOI: 10.1016/j.oret.2016.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Maguire MG. Assessing Intereye Symmetry and Its Implications for Study Design. Invest Ophthalmol Vis Sci 2020;61:27. [PMID: 32531057 DOI: 10.1167/iovs.61.6.27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Cheng QE, Daniel E, Pan W, Baumritter A, Quinn GE, Ying G. Plus Disease in Telemedicine Approaches to Evaluating Acute-Phase ROP (e-ROP) Study: Characteristics, Predictors, and Accuracy of Image Grading. Ophthalmology 2019;126:868-75. [DOI: 10.1016/j.ophtha.2019.01.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Liu YL, Ying GS, Quinn GE, Zhou XH, Chen Y. Extending Hui-Walter framework to correlated outcomes with application to diagnosis tests of an eye disease among premature infants. Stat Med 2021. [PMID: 34859902 DOI: 10.1002/sim.9269] [Reference Citation Analysis]
4 Cheng QE, Quinn GE, Daniel E, Baumritter A, Smith E, Ying GS; e-ROP Cooperative Group. Progression from preplus to plus disease in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study: incidence, timing, and predictors. J AAPOS 2020;24:354.e1-6. [PMID: 33212296 DOI: 10.1016/j.jaapos.2020.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Liu T, Tomlinson LA, Ying GS, Yang MB, Binenbaum G; G-ROP Study Group. Treatment of non-type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study. J AAPOS 2019;23:332.e1-6. [PMID: 31669723 DOI: 10.1016/j.jaapos.2019.08.279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin LY, Jensen AK, Quinn GE, Spiller A, Tomlinson LA, Ying GS, Binenbaum G. Symmetry of Disease in Retinopathy of Prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. Ophthalmic Epidemiol 2020;27:477-81. [PMID: 32522133 DOI: 10.1080/09286586.2020.1773872] [Reference Citation Analysis]
7 Rajan RP, Kohli P, Babu N, Dakshayini C, Tandon M, Ramasamy K. Treatment of retinopathy of prematurity (ROP) outside International Classification of ROP (ICROP) guidelines. Graefes Arch Clin Exp Ophthalmol 2020;258:1205-10. [PMID: 32322963 DOI: 10.1007/s00417-020-04706-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]